Gene · 2621
NIH grants2,018
NIH grants whose papers are about the gene, through NIH's grant-paper links.
841 to 860 of 2,018
Download this page as JSON| Grant | Title | GAS6 papers | Newest fiscal year |
|---|---|---|---|
| S10OD030335 | Ultra-sensitive multi-mode laser-scanning imaging system | 1 | 2021 |
| T32CA203702 | Molecular and Translational Oncology Research | 1 | 2021 |
| T32DC005356 | Advanced Research Training in Otolaryngology | 1 | 2021 |
| T32GM007171 | Medical Scientist Training Program | 1 | 2021 |
| T32GM007365 | Medical Scientist Training Program | 1 | 2021 |
| T32GM008602 | Graduate Training in the Pharmacological Sciences | 1 | 2021 |
| U01CA176058 | The Dana-Farber Cancer Institute Cancer Target Discovery and Development Center | 1 | 2021 |
| U01CA214114 | Proteogenomic studies aimed at understanding ovarian tumor responses to agents targeting the DNA damage response and translating this knowledge into clinical benefit | 1 | 2021 |
| U01CA214194 | Development of Protein Biomarkers in Post-DRE Urine for use in Liquid Biopsy of Prostate Cancer | 1 | 2021 |
| U01CA214300 | An organotypic model recapitulating colon cancer microenvironment and metastasis | 1 | 2021 |
| U01CA215798 | Systems approaches to understanding the relationships between genotype, signaling, and therapeutic efficacy | 1 | 2021 |
| U01CA217842 | Integrative bioinformatics and functional characterization of oncogenic driver aberrations in cancer | 1 | 2021 |
| U01CA217885 | A Rational Systematic Approach to Find Combinations of Pharmacologic and Immune Therapies that Target Identifiable Oncogenic States | 1 | 2021 |
| U01CA224193 | Disrupting the immune and drug-privileged microenvironment in pancreas cancer | 1 | 2021 |
| U01CA239069 | Reactome IDG portal: Pathway-based analysis and visualization of understudied human proteins | 1 | 2021 |
| U01DK062370 | Identifying Genes for Type 2 Diabetes: FUSION | 1 | 2021 |
| U01HG009088 | Powering whole genome sequence-based genetic discovery for common human diseases- Extended 2021-2022. | 1 | 2021 |
| U19AI118610 | Dengue Human Immunology Project Consortium (DHIPC) | 1 | 2021 |
| U19AI131130 | Engineering a human brain organoid-based platform to study neurotropic viruses | 1 | 2021 |
| U54CA156735 | NCCU-LCCC Partnership in Cancer Research | 1 | 2021 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2621/grants?page=43